The ESMO Preceptorship on Endometrial Cancer 2026: Lugano is a specialized educational program organized under the umbrella of the European Society for Medical Oncology (ESMO). This focused preceptorship is designed to provide in-depth, practice-oriented learning on the latest advances in the diagnosis and treatment of endometrial cancer.

Held in Lugano, Switzerland, the course brings together oncologists, gynecologic oncologists, and oncology trainees for an intensive program led by internationally recognized experts. The ESMO Preceptorship on Endometrial Cancer 2026 emphasizes interactive learning through case-based discussions, expert lectures, and multidisciplinary perspectives on patient management.

Key topics include molecular classification of endometrial cancer, personalized treatment strategies, immunotherapy, targeted therapies, management of advanced and recurrent disease, and the integration of new clinical trial data into daily practice. The program also highlights the importance of multidisciplinary care, including surgery, systemic therapy, and supportive care approaches.

Designed to support continuing medical education and improve clinical decision-making, the ESMO Preceptorship on Endometrial Cancer 2026 in Lugano offers participants a valuable opportunity to enhance their expertise, exchange knowledge with peers, and stay up to date with rapidly evolving standards in gynecologic oncology.